Ticker Details
Illumina, Inc. Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.
IPO Date:	July 28, 2000
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$18.91B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.15 | 1.72%
Avg Daily Range (30 D):	$2.24 | 1.80%
Avg Daily Range (90 D):	$2.41 | 1.84%

Institutional Daily Volume
Avg Daily Volume:	1.28M
Avg Daily Volume (30 D):	1.35M
Avg Daily Volume (90 D):	1.51M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	25,044
Avg Institutional Trade:	$6.99M
Avg Institutional Trade (30 D):	$9.99M
Avg Institutional Trade (90 D):	$10.78M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$20.67M
Avg Closing Trade (30 D):	$31.17M
Avg Closing Trade (90 D):	$33.62M
Avg Closing Volume:	117.82K

News

Apr 10, 2026 @ 9:45 AM Global Next-Generation Sequencing (NGS) Market to ... Source: Researchandmarkets.Com

Apr 7, 2026 @ 5:44 PM Global DNA Read, Write and Edit Market to Surge to... Source: Bcc Research

Apr 3, 2026 @ 9:00 AM Molecular Diagnostics Market Size is Expected to R... Source: Sns Insider

Mar 30, 2026 @ 8:58 AM Oncology Biomarkers Market Trends and Investment O... Source: Researchandmarkets.Com

Mar 23, 2026 @ 4:19 PM A $175 Million Move Into Sotera Health Signals Pot... Source: Jonathan Ponciano

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$5.47	$2.17	$5.47
Diluted EPS	$5.45	$2.16	$5.45
Revenue	$4.34B	$1.16B	$4.34B
Gross Profit	$2.87B	$759M	$2.87B
Net Income / Loss	$850M	$334M	$850M
Operating Income / Loss	$807M	$201M	$807M
Cost of Revenue	$1.47B	$400M	$1.47B
Net Cash Flow	$291M	$368M	$291M
PE Ratio	22.19

Splits
Sep 23, 2008	2:1